TLR4 and Parkinson disease: Studies have also demonstrated perturbed serum markers indicative of TLR4 activation (as assessed through altered LPS-binding protein levels) [14] and elevated endogenous DAMP high-mobility group box protein 1 (HMGB1) levels [61] in people with PD compared to healthy controls.